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Abstract: The researches were performed on male Wistar rats diabetised with Streptozotocin and treated with 
Eridiarom respectively Diavit (original phytotherapeutical products). It is noticed that the dynamic of 
magnesium is maintained high (over the normal values) in the lots treated with Eridiarom and Diavit in  the 
experimental period of 7 months; being superior to the witness lot. Both Eridiarom and Diavit determine the 
normalization of the status of followed microelements; which is representing an important aspect in the control 
of induced diabetes disease. 
 
MATERIAL AND METHODS 
 
The researches were performed on 4 lots of rats; Wistar race; males; 6 months old; 
medium mass of 150 grams over a period of 7 months. The animals were injected with 4 g/ 
100g / body Streptozotocin for the induction of diabetes. 
Periodically blood samples were collected for automated biochemical exams (KonelaB 
laboratory). 
The lots were composed as follows: 
Lot I – 8 animals experimentally sicken with Streptozotocin; treated with 2.7 
g/head/day Eridiarom. 
Lot II – 8 animals experimentally sicken with Streptozotocin; treated with Diavit (3 
g/head/day). 
Lot III – 8 animals experimentally sicken with Streptozotocin and untreated. 
Lot IV – 8 animals clinically healthy not sicken and untreated (healthy lot). 
The maintenance conditions; microclimate as well as the food were standard for the 
rats. 
The obtained data has been statistically processed and graphically represented.  
 
RESULTS AND DISCUSIONS 
 
Magnesium dynamic 
Magnesium is the forth cation as quantity in the body. It is involved in more than 300 
enzymatic systems; as adenosine tryphosfate metabolism (ATP); activation of creatin-kynasis; 
adenilat cyclases; and sodium potassium ATP-ase. Magnesium deficiency was involved in 
diseases like diabetes; arterial hypertension; cardiac arrhythmia; myocardial infarct and 
atherosclerosis. (1; 2) 
The majority of magnesium in the body is encountered in skeleton bone mass; better 
than 50% of the reserve; the rest is situated at the level of soft tissues; of which only 3% is 
situated extracellular. (4) 
 156 
Nutritional source of magnesium are green leafs vegetables; greens; nuts an animal 
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Graph 1. Magnesium dynamic at the lots treated with Eridiarom; compared to the studied lots 
 
Magnesium dynamic at the lot treated with Eridiarom (graph 1) is constant during the 
first two periods; 3.93 mg‰ at 3 months respectively 3.96 mg‰ at 5 months; followed by an 
easy increase to 4.28 mg‰ at 7 months. In the sickened lot the value is decreasing from 2.93 
mg‰ at 3 months to 2.28 mg‰ after 5 months; then to return to a value close to the initial of 
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 Graph 2. Magnesium dynamic at the lots treated with Diavit; compared to the studied lots 
 
In the lot treated with Diavit (graph 2) the mean value of magnesium (2.62 mg‰); is 
under the normal values of magnesium after 3 months; increasing and reaching noemal values 
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with 3.53 mg‰ after 5 month and with 4.28 mg‰ at 7 months; contrasting the sickened lot 
where the mean is decreasing from 2.93 mg‰ at 3 months to 2.28 mg‰ after 5 months; then 
to return to a value close to the initial of 2.91 mg‰ but without reaching the normal values of 
blood magnesium. 
 
Total calcium dynamic 
Calcium ions intervene in the contractility of myocardium and skeletal muscles and 
are indispensable for the normal function of the nervous system. They play an important role 
in coagulation and bone mineralization. 
Regulation of the serum calcium metabolism in the body is made by parathormone 
(PTH); calcitrol and calcitonin. (4; 7) 
Hypocalcaemia is due to a deficit in the synthesis of PTH by the thyroid gland or a 
deficit in the synthesis of vitamin D. this is manifested through latent and manifested tetany; 
osteomalacia and others. 
Hypercalcaemia is determined by an increase mobilization of bone calcium 
(osteoporosis) or increased intestinal absorption; primary hyperparatiroidism; bone metastases 
(mammary cancer; prostate; thyroid cancer; bronchopulmonary). (4; 7) 
Following the treatment; values are maintained almost equal; respectively 9.33 mg‰ 
at 3 months; 9.31 mg‰ at 5 months and 9.17 mg‰ at 7 months following Eridiarom 
treatment (graph 3). In the sickened lot it decreases to the value of 5.46 mg‰ at 3 months 
after the induction of diabetes; and it is noted a tendency of regulation of serum calcium after 
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Graph 4. Total calcium dynamic at the lots treated with Diavit; compared to the studied lots 
 
Visible changes occur in the lot treated with Diavit (graph 4) where the mean of the 
individuals reaches a value of 9.13 mg‰ and the has a decreasing tendancy towards 6.46 
mg‰ at 5 months and returns to the normal limits at the value of 9.40 mg‰ after 7 months. 
In the sickened lot serum calcium decreases to the value of 5.46 mg‰ at 3 months after the 




 Magnesium dynamic in the lot treated with Diavit is maintaining over the normal limits 
(excepting the 3rd month) reaching values of 4.28 mg‰. In the sickened lot the dynamic is 
maintained under the normal limit over the experimental period (2.91 – 2.281 mg‰). 
 Both Eridiarom and Diavit administered orally determine the maintenance; even the 
increase of magnesium in the treated lot. 
 Calcium dynamic in the lot treated with Eridiarom is maintained over the mean values 
during treatment (9.17 mg‰ – 9.317 mg‰); compared to the untreated lot where it 
reaches 5.463 mg‰ – 6.46 mg‰; a slightly increase being noticed at 7 months. 
 Calcium dynamic in the lot treated with Diavit is maintained over the mean value 
excepting the period of 5 months when a slightly decrease is noticed. 
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